Abstract
Norman Barrett described the columnar lined esophagus in 19501. In another paper written in 19572 he acknowledged the opinion of Allison and Johnstone3 that the condition represented an acquired disorder, associated with reflux. There is no useful information about its epidemiology before the widespread use of flexible endoscopy in the last quarter of the twentieth century.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barrett NR. Chronic peptic ulcer of the oesophagus and “esophagitis”. Br J Surg 1950; 38: 175–182.
Barrett NR. The lower esophagus lined by columnar epithelium. Surgery 1957; 41: 88–1894.
Allison PR, Johnstone AS. Oesophagus lined with gastric mucous membrane. Thorax 1953; 8: 87–93.
Philips RW, Wong RKH. Barrett’s esophagus: Natural history, incidence, etiology, and complications. Gastroenterol Clin N Am 1991; 20: 791.
Gruppo Operativo per to studio delle precancerosi dell esophago (GOSPE): Barrett’s esophagus: epidemiological and clinical results of a multicentric survey. Int J Cancer 1991; 48: 364.
Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918–922.
Nebel OT, Fornes MF, Castell DO. Symptomatic gastresophageal reflux: incidence and precipitating factors. Dig Dis Sci 1976; 21: 953–956.
Locke GR III, Talley NJ, Fett SR, Zinsmeister AR, Melton LJ Ill. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448–1456.
Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Canad Med Ass J 1982; 126: 46–48.
Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux in an adult population. Ann Med 1995; 27: 67–70.
Spechler SJ, Goyal P.K. Barrett’s esophagus. N Engl J Med 1986; 315: 362–371.
Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, Johnson DA, Cruess DF, Cotelingam JD, Gurney MS, Cattau EL. Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92: 118–124.
Mann NS, Tsai MF, Nair PK. Barrett’s esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989; 84: 1494–1496.
Cameron AJ, Kamath PS, Carpenter HA. Prevalence of Barrett’s esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology 1997; 112: A82.
Hassall E. Barrett’s esophagus: congenital or acquired? Am J Gastroenterol 1993; 88: 819–824.
Cameron At Lomboy CT. Barrett’s esophagus: age, prevalence and the extent of columnar epithelium. Gastroenterology 1992; 103: 1241–1245.
Hirota WK, Loughney TM, Lazas DJ, Maydonov itch CL, Rholl V, Wong RKH. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277–285.
Shoji T, Hongo M, Fukudo S, Handa M, Inaba H, Kano M, Narita H, Tamura D. Increasing incidence of Barrett’s esophagus and Barrett’s carcinoma in Japan. Gastroenterology 1999; 116: A 312.
Mason RJ, Bremner CG. The columnar-lined (Barrett’s) oesophagus in black patients. S Afr J Surg 1998; 36: 61–62.
Williamson WA, Ellis FH, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, Watkins E. Barrett’s esophagus. Prevalence and incidence of adenocarcinoma. Arch Int Med 1991; 151: 2212–2216.
Van Sandick JW, Van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H. Impact of endoscopie biopsy surveillance of Barrett’s oesophagus on patholological stage and clinical outcome of Barrett’s carcinoma. Gut 1998; 43: 216–222.
Harle IA, Finley RJ, Belsheim M, Bondy DC, Booth M, Lloyd D, McDonald JWD, Sullivan S, Valberg LS, Watson WC, Frei JV, Slinger R, Troster M, Meads GE, Duff JH. Management of adenocarcinoma in columnar-lined esophagus. Ann ThoracSurg 1985; 40: 330–335.
Sanfey H, Hamilton SR, Smith RRL, Cameron JL. Carcinoma arising in Barrett’s esophagus. Surg Gynecol Obstet 1985; 161: 570–4.
Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 1985; 313: 857–859.
Menke-Pluymers MBE, Schoute NW, Mulder AH, Hop WCJ, Van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett’s oesophagus. Gut 1992; 33: 1454–1458.
Conio M, Cameron AJ, Romero Y, Branch CD, Schleck CD, Burgart LJ, Zinsmeister AR, Locke GR III. Barrett’s esophagus and adenocarcinoma. Prevalence and incidence in Olmsted County, Minnesota. Gastroenterology 1999; 116: A384.
Prach AJ, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett’s oesophagus: education, enthusiasm, or epidemiology? Lancet 1997; 350: 933.
Chow WC, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474–7.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–831.
Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett’s esophagus. Dig Dis Sci 1992; 37: 137–143.
Crabb DW, Berk MA, Hall TR, Conneally PM, Biegel AA, Lehman GA. Familial gastroesophageal reflux and development of Barrett’s esophagus. Ann lnt Med 1985; 103: 52–54.
Jochem VJ, Fuerst PA, Fromkes JJ. Familial Barrett’s esophagus associated with adenocarcinoma. Gastroenterology 1992; 102: 1400–1402.
Fahmy N, King JF. Barrett’s esophagus: an acquired condition with genetic predisposition. Am J Gastroenterol 1993; 88: 1262–1265.
Romero Y, Cameron AJ, Locke Ill GR, Schaid DJ, Slezak JM, Branch CD, Melton III LJ. Familial aggregation of gastroesophageal reflux in patients with Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 1997; 113: 1449–1456.
Trudgill NJ, Kapur KC, Riley AS. Familial clustering of reflux symptoms. Am J Gastroenterol 1999; 94: 1172–1178.
Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastrooesophageal junction. Lancet 1994; 344: 1533–1536.
Johnson MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical chararteristics of short segments of specialized intestinal metaplasia in the distal esophagus at routine endoscopy. Am J Gastroenterol 1996; 91: 1507–1511.
Voutilanen M, Farkkila M, Juhola M, Nuorva K, Mauranen K, Mantynen T, Kunnamo I, Mecklin J-P, Sipponen P. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. Am J Gastroenterol 1999; 94: 913–918.
Trudgill NJ, Suvama SK, Kapur KC, Riley SA. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic endoscopy. Gut 1997: 41: 585–589.
Morales T, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997; 92: 414–418.
Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett’s esophagus: prevalence, diagnosis and associations. Gut 1997; 40: 710–715.
Tytgat GNJ. Does endoscopie surveillance in esophageal columnar metaplasia have any real value? Endoscopy 1995; 27: 19–26.
Van der Burgh A, Dees J, Hop WCJ, et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s esophagus. Gut 1996; 39: 5–8.
Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 212–215.
Golematis B, Tzardis P, Hatzikostas P, Papadimitriou K, Haritopoulos N. Changing pattern of distribution of carcinoma of the stomach. Br J Surg 1990; 77: 63–64.
Antonioli DA, Goldman H. Changes in the location and type of gastric adenocarcinoma. Cancer 1982; 50: 775–781
Rios-Castellanos E, Sitas F, Shepherd NA, Jewell DP. Changing pattern of gastric cancer in Oxfordshire. Gut 1992; 33: 1312–1317.
Puestow CB, Gillesby WJ, Guynn VL. Cancer of the esophagus. Arch Surg 1955; 70: 662–668.
Turnbull ADM, Goodner JT. Primary adenocarcinoma of the esophagus. Cancer 1968; 22: 915–918.
Rahamim J, Cham CW. Oesophagogastrectomy for carcinoma of the oesophagus and cardia. Br J Surg 1993; 80: 1305–1309.
Putnam JB, Suell DM, McMurtrey MJ, Ryan MB, Walsh GL, Natarajan G, Roth JA. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 1994; 57: 319–325.
Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–1289.
Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510–513.
Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049–53.
Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N. Adenocarcinoma of the esophagus and Barrett’s esophagus: a population-based study. Am J Gastroenterol 1999; 94: 86–91.
Lord RVN, Law MG, Ward RL, Giles GG, Thomas RJS, Thursfield V. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroent Hepatol 1998; 13: 356–362.
Rogers EL, Goldkind SF, Iseri OA, Bustin M, Goldkind L, Hamilton SR, Smith RRL. Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett’s esophagus. J Clin Gastroenterol 1986; 8: 613–618.
Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer 1988; 61: 612–617.
Kabat GC, Ng SKC, Wynder EL. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes and Control 1993; 4: 123–132.
Brown LM, Silverman DT, Pottern LM, Schoenberg JB, Greenberg RS, Swanson GM, Liff JM, Schwartz AG, Hayes RB, Blot WJ, Hoover RN. Cancer Causes and Control 1994; 5: 333–340.
Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinomas versus squamous cell carcinoma. Cancer Epidemiology Biomarkers and Prevention 1995; 4: 85–92.
Zhang ZF, Kurtz RC, Sun M, Karpeh M, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers and Prevention 1996; 5: 761–768.
Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan WI, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF. Tobacco, alcohol and socioeconomic status and adenocarcinoma of the esophagus and gastric cardia. J Natl. Cancer Inst 1997; 89: 1277–1284.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. The role of tobacco, snuff, and alcohol use in the etiology of esophageal and gastric cardia cancer. Ph D thesis, Karolinska Institute, Stockholm, 1999.
Chow WH, Blot WJ, Vaughan WJ, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.. J Natl. Cancer Inst 1998; 90: 150–155.
Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Int Med 1999; 130: 883–890.
Mokdad AL, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991–1998.
Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF. An inverse relationship between cagA strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588–590.
Lagergren J, Nyren O. Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers and Prevention 1998; 7: 913–915.
Vaughan TL, Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H, West AB, Blot WJ, Fraumeni JF. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers and Prevention 1998; 7: 749–75
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Cameron, A.J. (2001). Epidemiology of Barrett’s Esophagus and Adenocarcinoma. In: Tilanus, H.W., Attwood, S.E.A. (eds) Barrett’s Esophagus. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0829-6_21
Download citation
DOI: https://doi.org/10.1007/978-94-017-0829-6_21
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5860-7
Online ISBN: 978-94-017-0829-6
eBook Packages: Springer Book Archive